All News

Medicare’s $35 insulin cap cuts cost swings, boosts adherence for high-burden patients, and highlights pharmacists’ role in preventing rationing.

As pneumococcal disease continues to rise since the COVID-19 pandemic, researchers looked at the need to escalate the management of serotype surveillance and vaccine coverage.

BA.3.2 variant spreads globally, testing vaccine matches as the FDA backs XFG immunizations.

The Age-Friendly Pharmacy certification and the 4Ms reshape senior care, teamwork, and deprescribing by putting the patient in the center of care.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

Alabama bans research-grade peptides for patients amid FDA reviewing 12 peptides for compounding use.

New 9-year data shows some high-risk prediabetes patients progress to type 2 diabetes despite 8% weight loss.

Federal court blocks abrupt childhood vaccine schedule changes, raising insurance and liability uncertainty as pharmacies navigate shifting guidance and growing parent hesitancy.

Recent research data assessed the potential use of GLP-1s for reducing the progression of total knee arthroplasty.

The executive order calls to realign core childhood vaccine recommendations with scientific evidence and best practices of peer, developed nations.

Pharmacists can prevent heat illness through medication reviews and safety plans.

Exploring both the PCV20 and PCV21 pneumococcal vaccines, researchers compare the differences in immune effects between patients at 50 and 65 years old.

Bepirovirsen suggests that a finite 24-week treatment course can achieve a functional cure defined as sustained undetectable hepatitis B surface antigen.

Pharmacists flag risky medications, safeguard cold-chain supplies, and counsel with the HEAT checklist.

Pharmacists help women choose safer hormone replacement therapy or nonhormonal relief options.

The approval arrives prior to the Prescription Drug User Fee Act action date of June 16, 2026.

In a meta-analysis conducted between 2013 and 2023, researchers explore the overall impact of interventions geared toward boosting pneumococcal vaccination rates.

Older adults with type 2 diabetes often juggle 5 or more different prescriptions.

This regulatory milestone establishes inhaled insulin as the first and only noninjectable mealtime insulin option for children and adolescents.

Learn practical do’s and don’ts for male pharmacists to deliver private, inclusive, evidence-based birth control counseling patients trust.

Represented by Frier Levitt, multiple hospital systems filed lawsuits on May 21, 2026, targeting a variety of entities existing under CVS Health.

FDA updates Tremfya label in psoriatic arthritis, confirming it slows structural joint damage and helping patients protect mobility while easing symptoms.

Boost patient demand for pharmacist prescribing with clear messaging, service pages, in-store prompts, social posts, and local partnerships.

From supporting MTM services to reaching unhoused populations, the 340B program is a powerhouse for patient care, access, and affordability.

This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.

New FDA label lets linaclotide treat functional constipation in children 2 to 5, with dosing tips, mixing options, and key safety warnings.

Utah protocol streamlines large-volume immunoglobulin for measles-exposed infants as outbreaks surge.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.